Dogbeda F. Mackenzie

FDA investigator

Appears on 14 documents from 2021 to 2025, mostly at sites in California. Most often cites production record review (21 CFR 211.192).

14
Documents on file
6.0
Observations per 483
2021
First seen
2025
Most recent

What they cite most

From 84 observations

Activity by year

2021: 6, 2022: 2, 2023: 2, 2024: 2, 2025: 2

Where

California 8 · Arizona 2 · Colorado 1 · Singapore 1 · Tennessee 1 · Texas 1

Is Dogbeda F. Mackenzie coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

14 documents, newest first
FirmOpen
483 Wells Pharmacy, Inc.Apr 25, 2025 · Dyersburg, Tennessee
483 Certified Laboratories, LLCJan 7, 2025 · Burbank, California
483 Tailstorm Health Inc.Sep 24, 2024 · Phoenix, Arizona
483 Empower PharmacyAug 28, 2024 · Houston, Texas
483 Alcon Singapore Manufacturing Pte. Ltd.Sep 8, 2023 · Singapore, Singapore
483 Central Admixture Pharmacy ServicesJul 31, 2023 · Phoenix, Arizona
483 NeilMed Pharmaceuticals, IncDec 2, 2022 · Santa Rosa, California

About this profile

What does Dogbeda F. Mackenzie inspect?

Dogbeda F. Mackenzie appears on 14 documents on file covering 13 sites, mostly in California.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.22 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Dogbeda F. Mackenzie is dated Apr 25, 2025.